The Food & Drug Administration recently sent warning letters to businesses that are selling abortion pills online that the federal entity deemed unapproved and mislabeled.
The FDA sent a warning letter last week to Aid Access, a website that claims to provide safe abortion pills for “women, girls and trans men.”
Signed by Thomas Christi, director of the Office of Drug Security, Integrity, & Recalls at FDA, the letter says that the website has introduced “misbranded and unapproved new drugs” in “interstate commerce” in violation of federal law.
Two specific examples cited by the FDA were the drugs mifepristone and misoprostol, which were labeled “unapproved,” adding that “they are not generally recognized as safe and effective for their labeled use.”
“Aidaccess.org facilitates the sale to U.S. consumers of unapproved mifepristone in a regimen with unapproved misoprostol labeled for the termination of pregnancy,” states the letter.
“No approved applications pursuant to section 505 of the FD&C Act are in effect for this product. Accordingly, its introduction or delivery for introduction into interstate commerce violates sections 301(d) (21 U.S.C. § 331(d)] and 505(a) (21 U.S.C. § 355(a)] of the FD&C Act.”
Another warning letter was sent last week to Rablon, an online pharmacy network that oversees several websites including some that sell abortion pills.
Click here to read more.
SOURCE: Christian Post, Michael Gryboski